Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
29 studies found for:    Open Studies | "Arthritis, Juvenile Rheumatoid"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Arthritis, Juvenile Rheumatoid" (29 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Recruiting Special Investigation (All Case Survey) in Patients With Juvenile Idiopathic Arthritis
Condition: Arthritis, Juvenile Rheumatoid
Intervention:
2 Not yet recruiting Identification of Genes Involved in Juvenile Idiopathic Arthritis by Wholel Exome Sequencing
Condition: Arthritis, Juvenile Rheumatoid
Intervention: Biological: Blood sample
3 Recruiting Pharmacovigilance in Juvenile Idiopathic Arthritis Patients Treated With Biologic Agents and/or Methotrexate
Condition: Juvenile Idiopathic Arthritis
Intervention:
4 Recruiting Massage Therapy in Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Interventions: Other: Massage therapy;   Other: Standard care
5 Recruiting Oxidation Rates of the Different Substrates During Exercise in Children and Adolescents With Juvenile Idiopathic Arthritis. Case-control Study and Cases Treated / Cases Not Treated With Anti-TNFα
Condition: Juvenile Idiopathic Arthritis
Intervention: Other: anti-TNFα
6 Recruiting An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention:
7 Recruiting Long-Term Safety Study Of Tofacinib In Patients With Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: Tofacitinib
8 Recruiting Biomarkers in Idiopathic Juvenile Arthritis
Condition: Idiopathic Juvenile Arthritis
Intervention: Other: blood sample for identifying biomarkers
9 Recruiting A Study of Subcutaneously Administered Tocilizumab in Participants With Systemic Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: Tocilizumab
10 Recruiting Extension Study Evaluating the Safety and Efficacy of Subcutaneous Tocilizumab (RoActemra/Actemra) Administration in Systemic and Polyarticular-Course Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: Tocilizumab
11 Recruiting A Study of Decreased Dose Frequency in Participants With Systemic Juvenile Arthritis Who Experience Laboratory Abnormalities During Treatment With RoActemra/Actemra (Tocilizumab)
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: Tocilizumab
12 Recruiting An Open-label, Ascending, Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA)
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: Sarilumab SAR153191 (REGN88)
13 Recruiting Prediction of Temporomandibular Involvement in Juvenile Idiopathic Arthritis
Conditions: Juvenile Idiopathic Arthritis;   Temporomandibular Arthritis
Intervention:
14 Not yet recruiting Treatment Tapering in JIA With Inactive Disease
Condition: Juvenile Idiopathic Arthritis
Interventions: Drug: etanercept;   Drug: adalimumab;   Drug: Abatacept;   Drug: Tocilizumab
15 Recruiting Therapeutic Alliance is it Associated With Better Compliance Amongst Children With Juvenile Idiopathic Arthritis ?
Condition: Juvenile Idiopathic Arthritis
Intervention:
16 Recruiting Patient Centered Adaptive Treatment Strategies Using Bayesian Causal Inference
Condition: Juvenile Idiopathic Arthritis
Intervention:
17 Not yet recruiting Jointly Managing JIA Online: An Internet-based Psycho-educational Game for Children With JIA and Their Parents
Condition: Juvenile Idiopathic Arthritis
Interventions: Behavioral: Game;   Other: Usual Care
18 Recruiting Efficacy Study Of Tofacitinib In Pediatric JIA Population
Condition: Juvenile Idiopathic Arthritis
Interventions: Drug: CP-690,550 (tofacitinib);   Other: placebo
19 Recruiting ß-SPECIFIC 4 Patients: Study of Pediatric EffiCacy and Safety wIth FIrst-line Use of Canakinumab
Condition: Systemic Juvenile Idiopathic Arthritis (SJIA)
Intervention: Drug: ACZ885 150 mg (Canakinumab)
20 Recruiting Cellular and Molecular Adaptations to Exercise-induced Inflammatory Response in Children With Autoimmune Diseases
Condition: Juvenile Idiopathic Arthritis
Intervention: Procedure: Controlled physical activity

   Previous Page Studies Shown (1-20) Next Page (21-29) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.